What Is TECH Fair Value?
Bio-Techne (TECH) fair value estimate using multiple valuation models, updated daily.
As of October 14, 2026, Bio-Techne (TECH) has a composite fair value estimate of $21.62 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $72.48, suggesting the stock is overvalued by 70.2%.
Data as of October 14, 2026 (today)
Composite Fair Value
Overvalued4 of 4 models$21.62
vs. current price of $72.48(-70.2%)
How Is TECH Fair Value Calculated?
Four independent models estimate what TECH is worth. Each uses different inputs and assumptions. The composite blends them by weight.
TECH Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$23.24
-67.9%Overvalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$4.89
-93.3%Overvalued
Inputs used
TECH Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$24.88
-65.7%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$20.37
-71.9%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $72.48 is 67.9% above this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $251.6M | $225.7M |
| Year 2 | $275.5M | $221.9M |
| Year 3 | $301.8M | $218.1M |
| Year 4 | $330.6M | $214.4M |
| Year 5 | $362.1M | $210.8M |
| Year 6 | $396.6M | $207.2M |
| Year 7 | $434.5M | $203.6M |
| Year 8 | $475.9M | $200.2M |
| Year 9 | $521.3M | $196.8M |
| Year 10 | $571.0M | $193.4M |
| Terminal Value | $6.55B | $2.22B |
What Are TECH's Key Financial Metrics?
Earnings & Growth
Current Price
$72.48
EPS (TTM)
$1.16
Forward P/E
31.3
Profit Margin
15.0%
Cash & Balance Sheet
Free Cash Flow
229.7M
EBITDA
334.1M
Book Value
$13.51
Total Debt
289.1M
What Do Analysts Say About TECH?
Low
$50.00
Average
$70.50
High
$73.00
Upside
-2.7%
TECH Fair Value FAQ
What is the fair value of TECH?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), TECH's estimated fair value is $21.62. The stock is currently trading at $72.48, which makes it overvalued by our analysis.
How is TECH's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is TECH overvalued or undervalued?
Based on our analysis, TECH is overvalued. The current price of $72.48 is 70.2% above our estimated fair value of $21.62.
What do Wall Street analysts say about TECH?
10 analysts cover Bio-Techne with a consensus rating of "Hold." The average price target is $70.50, ranging from $50.00 to $73.00. This implies 2.7% downside from the current price.